New Alzheimer's Trials Could Produce The Most Important Drugs In History

Loading...
Loading...

Welcome to the July 21st edition of This Week on Estimize. We are pleased to be joined by Joe McCann, former biotech analyst and founder of Slingshot Insights, a company that works to provide professional caliber investment tools to sophisticated retail investors through interviews with subject matter experts and management access meetings.

In this episode, Leigh and Joe discuss the two big Alzheimer's trial results that will be released Wednesday morning from Eli Lilly and Co LLY, as well as a flurry of earnings results from those two companies along with Gilead Sciences, Inc. GILD, Celgene CorporationCELG, XOMA Corp XOMA, Retrophin Inc RTRX, Zogenix, Inc. ZGNX, United Therapeutics Corporation UTHR and more.

Posted In: Analyst ColorBiotechMoversGeneral
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...